Join
Live feed
·
PRReleasevia Quantisnow
BioNexus Gene Lab Corp logo

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization

ByQuantisnow·Wall Street's wire, on your screen.
BGLC· BioNexus Gene Lab Corp
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BGLC (BioNexus Gene Lab Corp) and more on Quantisnow.